Effect of Rifampicin Treatment on the Metabolism of Oestradiol and 17alpha-ethinyloestradiol by Human Liver Microsomes

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1975 Jun 13

PMID 1233229

Citations 34

Authors

H M Bolt

H Kappus

M Bolt

Affiliations

Soon will be listed here.

Abstract

Liver biopsies were obtained from four patients treated with rifampicin 600 mg for 6-10 days. Hepatic microsomes were incubated with an NADPH-regenerating system and the substrates [2,4,6,7-3H] oestradiol, [6,7-3H] oestradiol, [2,4,6,7-3H] ethinyloestradiol and [6,7-3H] ethinyloestradiol. The hydroxylation rates of these steroids at the labelled positions of rings A and B were determined by measuring the transformation of tritium into HTO by the microsomal enzymes. Comparison with previously published data showed that treatment with rifampicin caused a fourfold increase in the rate of hydroxylation of oestradiol and ethinyloestradiol at positions C-2/C-4 of ring A and C-6/C-7 of ring B. The acceleration of oestrogen hydroxylation by rifampicin was paralleled by an increase in microsomal cytochrome P-450, and also by microsomal reduction of rifampicin-quinone, a reactive metabolite of rifampicin. The increased aromatic hydroxylation of oestradiol and ethinyloestradiol leads to enhancement of their irreversible binding to microsomal protein. The data provide an explanation for the diminished efficacy of oestrogens in contraceptive formulations given to patients under treatment with rifampicin.

Citing Articles

Dynamic Ir(III) Photosensors for the Major Human Drug-Metabolizing Enzyme Cytochrome P450 3A4.

Denison M, Ahrens J, Dunbar M, Warmahaye H, Majeed A, Turro C Inorg Chem. 2023; 62(7):3305-3320.

PMID: 36758158 PMC: 10268476. DOI: 10.1021/acs.inorgchem.3c00059.

Roles of cytochrome P450 enzymes in pharmacology and toxicology: Past, present, and future.

Guengerich F Adv Pharmacol. 2022; 95:1-47.

PMID: 35953152 PMC: 9869358. DOI: 10.1016/bs.apha.2021.12.001.

Recent Advances in Electrochemical Biosensors Based on Enzyme Inhibition for Clinical and Pharmaceutical Applications.

El Harrad L, Bourais I, Mohammadi H, Amine A Sensors (Basel). 2018; 18(1).

PMID: 29315246 PMC: 5795370. DOI: 10.3390/s18010164.

Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes.

Li A, Hartman N, Lu C, Collins J, Strong J Br J Clin Pharmacol. 1999; 48(5):733-42.

PMID: 10594476 PMC: 2014360. DOI: 10.1046/j.1365-2125.1999.00081.x.

Inhibition and induction of cytochrome P450 and the clinical implications.

Lin J, Lu A Clin Pharmacokinet. 1998; 35(5):361-90.

PMID: 9839089 DOI: 10.2165/00003088-199835050-00003.

References

Maggi N, Pasqualucci C, BALLOTTA R, SENSI P . Rifampicin: a new orally active rifamycin. Chemotherapy. 1966; 11(5):285-92. DOI: 10.1159/000220462. View

Davies D, Thorgeirsson S . Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man. Ann N Y Acad Sci. 1971; 179:411-20. DOI: 10.1111/j.1749-6632.1971.tb46918.x. View

Abdel-Aziz M, Williams K . Metabolism of radioactive 17alpha-ethynylestradiol by women. Steroids. 1970; 15(5):695-710. DOI: 10.1016/s0039-128x(70)80074-5. View

Breuer H, Reimers D . [Effects of rifampicin on the menstrual cycle and on oestrogen excretion in patients taking oral contraceptives]. Dtsch Med Wochenschr. 1973; 98(33):1521-3. DOI: 10.1055/s-0028-1107071. View

Fishman J, Hellman L, Zumoff B, Cassouto J . Pathway and stereochemistry of the formation of estriols in man. Biochemistry. 1966; 5(6):1789-94. DOI: 10.1021/bi00870a003. View

Nelson E, Raj P, Belfi K, Masters B . Oxidative drug metabolism in human liver microsomes. J Pharmacol Exp Ther. 1971; 178(3):580-8. View

Ackermann E, Heinrich I . [The activity of N- and O-demethylase in the human liver]. Biochem Pharmacol. 1970; 19(2):327-42. DOI: 10.1016/0006-2952(70)90190-5. View

Bolt H, Kappus H, Bolt M . Letter: Rifampicin and oral contraception. Lancet. 1974; 1(7869):1280-1. DOI: 10.1016/s0140-6736(74)90025-7. View

Bolt H, Bolt W . Pharmacokinetics of mestranol in man in relation to its oestrogenic activity. Eur J Clin Pharmacol. 1974; 7(4):295-305. DOI: 10.1007/BF00560348. View

10.

Ball P, Gelbke H, Haupt O, Knuppen R . Metabolism of 17alpha-ethynyl-(4-14C)oestradiol and (4-14C)mestranol in rat liver slices and interaction between 17alpha-ethynyl-2-hydroxyoestradiol and adrenalin. Hoppe Seylers Z Physiol Chem. 1973; 354(12):1567-75. DOI: 10.1515/bchm2.1973.354.2.1567. View

11.

Omura T, Sato R . THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964; 239:2370-8. View

12.

Syvalahti E, Pihlajamaki K, Iisalo E . Letter: Rifampicin and drug metabolism. Lancet. 1974; 2(7874):232-3. DOI: 10.1016/s0140-6736(74)91547-5. View

13.

SUNAHARA S, Nakagawa H . Metabolic study and controlled clinical trials of rifampin. Chest. 1972; 61(6):526-32. DOI: 10.1378/chest.61.6_supplement.526. View

14.

Fleischmann R, MATTENHEIMER H, Holmes A, Remmer H . Micromethod for the preparation of a microsomal fraction from rat and human liver by differential sedimentation. Biochem Biophys Res Commun. 1975; 62(2):289-95. DOI: 10.1016/s0006-291x(75)80136-7. View

15.

Edwards O, Galley J, Hunter J, Tait A . Changes in cortisol metabolism following rifampicin therapy. Lancet. 1974; 2(7880):548-51. View

16.

Cargill D, Steinetz B, Gosnell E, BEACH V, Meli A, FUJIMOTO G . Fate of ingested radiolabeled ethynylestradiol and its 3-cyclopentyl ether in patients with bile fistulas. J Clin Endocrinol Metab. 1969; 29(8):1051-61. DOI: 10.1210/jcem-29-8-1051. View

17.

Reimers D, JEZEK A . [The simultaneous use of rifampicin and other antitubercular agents with oral contraceptives]. Prax Pneumol. 1971; 25(5):255-62. View

18.

Bolt W, Kappus H, Bolt H . Ring A oxidation of 17alpha-ethynylestradiol in man. Horm Metab Res. 1974; 6(5):432. DOI: 10.1055/s-0028-1095729. View

19.

Bolt H, Kappus H . Irreversible binding of ethynyl-estradiol metabolites to protein and nucleic acids as catalyzed by rat liver microsomes and mushroom tyrosinase. J Steroid Biochem. 1974; 5(2):179-84. DOI: 10.1016/0022-4731(74)90126-5. View

20.

Warren R, FOTHERBY K . Plasma levels of ethynyloestradiol after administration of ethynyloestradiol or mestranol to human subjects. J Endocrinol. 1973; 59(2):369-70. DOI: 10.1677/joe.0.0590369. View